Dr. Steven Braithwaite
CSO at Alkahest, United States
Steven Braithwaite, PhD, is Chief Scientific Officer of Alkahest, a Grifols company, leading research into therapeutics for age-related disorders. He is also adjunct Professor of Neurology at Rutgers University and has held previous positions at Circuit Therapeutics, Signum Biosciences, Wyeth and AGY Therapeutics. Dr Braithwaite is a graduate of the University of Cambridge, received his PhD at the University of Bristol and performed Postdoctoral research at Stanford University. His interests have focused in the areas of Aging, Alzheimer’s and Parkinson’s Diseases, with a passion to bring innovative treatments to patients.
Parallel Session: New perspectives in the management of age-related diseases
- 10 November, 2021
- 11:00 - 12:30